The DOI matches its Crossref record; 169 of the 175 references it cites were found in a registry or an index.
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Open accessAbstract
Cancer cells propagated in three-dimensional (3D) culture systems exhibit physiologically relevant cell-cell and cell-matrix interactions, gene expression and signaling pathway profiles, heterogeneity and structural complexity that reflect in vivo tumors. In recent years, development of various 3D models has improved the study of host-tumor interaction and use of high-throughput screening platforms for anti-cancer drug discovery and development. This review attempts to summarize the various 3D culture systems, with an emphasis on the most well characterized and widely applied model - multicellular tumor spheroids. This review also highlights the various techniques to generate tumor spheroids, methods to characterize them, and its applicability in cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This physiochemical gradient generally induces the formation of three concentric zones on a spheroid -an anoxic core in the center containing necrotic cells, a middle hypoxic zone that has a low concentration of oxygen and nutrients, and an outer zone containing highly proliferative cells [53].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer spheroids are arguably the simplest in vitro 3D tumor models [114,115].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, various tumor spheroids have been fabricated by embedding cancer cells into protein‐based hydrogels such as Matrigel,[ 64 ] fibrin,[ 65 ] and collagen[ 66 ] as they incorporate specific cell‐adhesive motifs and enzymatic‐mediated matrix degradation which are beneficial to cell proliferation.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An important aspect to consider is uniformity in size and homogeneity to ensure that the results are not in fl uenced by these factors [53].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“Tumor cell spheroids are especially useful for studying cancers that form tumor embolus, or a closely packed tumor cell cluster, as happens in in fl ammatory breast cancer [53].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“Three-dimensional multicellular tumor spheroids have emerged as more representative in vitro models that capture essential features of tumor architecture, stromal interactions, and microenvironmental resistance mechanisms.”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Spheroids exhibit spatially organized regions of proliferation, quiescence, and hypoxia, and can incorporate non-tumor cells to mimic tumor–stroma crosstalk.”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“By mimicking the hierarchical structure, proliferation gradients, and stromal interactions found in native tumor tissues, spheroids provide a more physiologically relevant context for evaluating anticancer agents and delivery systems [16,17].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“These gradients typically emerge when spheroids exceed ~500 μm in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, 2D cultured cells are artificially polarized when their cytoskeleton rearranges as they are stretched on the culture plate, which in turn causes these cultured cells to express genes and proteins which are atypical [56].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [56]
In the citing paper
“Spheroids [98, 99] are, in general, considered similar to an early vascular stage of tumors”
In the citing paper
“Moreover, this gradient leads to the formation of concentric zones in the spheroids with a center containing an anoxic core with necrotic cells, a middle zone containing hypoxic cells, and an outer zone of highly proliferative cells, recapitulating the properties of an in vitro tumor [379].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [379]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Damm, T. B., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,552
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,857
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Hydrogel: Preparation, characterization, and applications: A review
Ahmed, E. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2013.07.006 · Cited by 5,800
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
Nonlinear magic: multiphoton microscopy in the biosciences
Zipfel, W. R., Williams, R. M., & Webb, W. W. (2003) · Nature Biotechnology · doi:10.1038/nbt899 · Cited by 3,911
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000433566 · Cited by 3,519
Flagged first, then by citations
6 of the 175 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Chandrasekaran, 2014, Vol. 9
- Onodera, 2014, Vol. 124
Cited by
Sorted by citations
Items 101–200 of 920
Spheroids in cancer research: Recent advances and opportunities
Arora, S., Singh, S., Mittal, A. K., Desai, N., Khatri, D. K., Gugulothu, D. B., Lather, V., Pandita, D., & Vora, L. K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106033 · Cited by 76
Gutzweiler, L., Kartmann, S., Tröndle, K., Benning, L., Finkenzeller, G., Zengerle, R., Koltay, P., Stark, G. B., & Zimmermann, S. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7218 · Cited by 71
Hagemann, J., JACOBI, C., Hahn, M., Schmid, V., Welz, C., Schwenk‐Zieger, S., Stauber, R. H., Baumeister, P., & Becker, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11555 · Cited by 73
Facile Tumor Spheroids Formation in Large Quantity with Controllable Size and High Uniformity
Shi, W., Kwon, J., Huang, Y., Tan, J., Uhl, C. G., He, R., Zhou, C., & Liu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-25203-3 · Cited by 69
Emerging tumor-on-chips with electrochemical biosensors
Lei, L., Ma, B., Xu, C., & Liu, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116640 · Cited by 71
Quantitative Proteomic and Phosphoproteomic Comparison of 2D and 3D Colon Cancer Cell Culture Models
Yue, X. S., Lukowski, J. K., Weaver, E. M., Skube, S. B., & Hummon, A. B. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00342 · Cited by 69
Olofsson, K., Carannante, V., Ohlin, M., Frisk, T. W., Kushiro, K., Takai, M., Lundqvist, A., Önfelt, B., & Wiklund, M. (2018) · Lab on a Chip · doi:10.1039/c8lc00537k · Cited by 68
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
Menyailo, M. E., Tretyakova, M. S., & Denisov, E. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051696 · Cited by 67
Redmond, J., McCarthy, H. O., Buchanan, P., Levingstone, T. J., & Dunne, N. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.111944 · Cited by 71
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
Tellez-Gabriel, M., Cochonneau, D., Cadé, M., Jubelin, C., Heymann, M., & Heymann, D. (2018) · Cancers · doi:10.3390/cancers11010019 · Cited by 68
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
“These gradients typically emerge when spheroids exceed ~500 µ m in diameter, with proliferative cells localized to the outer rim, quiescent cells residing in intermediate zones, and hypoxic or necrotic cores forming at the center due to limited diffusion [17,184,185].”
Ganguli, A., Mostafa, A., Saavedra, C., Kim, Y., Le, P., Faramarzi, V., Feathers, R. W., Berger, J., Ramos-Cruz, K. P., Adeniba, O. O., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc1323 · Cited by 66
Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression
Vidavsky, N., Kunitake, J. A. M. R., Diaz-Rubio, M. E., Chiou, A. E., Loh, H.-C., Zhang, S., Mašić, A., Fischbach, C., & Estroff, L. A. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00932 · Cited by 63
Watson, P. M. D., Kavanagh, E., Allenby, G., & Vassey, M. (2017) · SLAS Discovery · doi:10.1177/2472555217691450 · Cited by 74
3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing
Ahn, J., Kim, D., Koo, D.-J., Lim, J., Park, T., Lee, J., Ko, J., Kim, S., Kim, M., Kang, K., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.10.009 · Cited by 64
Blanchette-Farra, N., Kita, D., Konstorum, A., Tesfay, L., Lemler, D. J., Hegde, P., Claffey, K. P., Torti, F. M., & Torti, S. V. (2018) · Oncogene · doi:10.1038/s41388-018-0243-y · Cited by 63
Monteiro, C. F., Santos, S. C., Custódio, C. A., & Mano, J. F. (2020) · Advanced Science · doi:10.1002/advs.201902398 · Cited by 61
Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 67
Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research
Salinas-Vera, Y. M., Valdés, J., Pérez‐Navarro, Y., Mandujano-Lázaro, G., Marchat, L. A., Ramos‐Payán, R., Núñez-Olvera, S. I., Pérez‐Plasencia, C., & López‐Camarillo, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.826113 · Cited by 74
Khan, M. S., Hwang, J., Lee, K., Choi, Y., Seo, Y., Jeon, H., Hong, J. W., & Choi, J. H. (2019) · Cancers · doi:10.3390/cancers11101464 · Cited by 60
Stejskalová, A., Fincke, V. E., Nowak, M. K., Schmidt, Y., Borrmann, K., von Wahlde, M., Schäfer, S. D., Kiesel, L., Greve, B., & Götte, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83645-8 · Cited by 58
Sano, E., Mori, C., Nashimoto, Y., Yokokawa, R., Kotera, H., & Torisawa, Y. (2018) · Biomicrofluidics · doi:10.1063/1.5027183 · Cited by 62
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies
Stanković, T., Ranđelović, T., Dragoj, M., Burić, S. S., Fernández, L. J., Ochoa, I., Pérez‐García, V. M., & Pešić, M. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100753 · Cited by 62
Mathematical Model of Tumour Spheroid Experiments with Real-Time Cell Cycle Imaging
Jin, W., Spoerri, L., Haass, N. K., & Simpson, M. J. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00878-4 · Cited by 60
Photothermal effect by NIR-responsive excretable ultrasmall-in-nano architectures
Cassano, D., Santi, M., D’Autilia, F., Mapanao, A. K., Luin, S., & Voliani, V. (2019) · Materials Horizons · doi:10.1039/c9mh00096h · Cited by 61
Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models
Ziółkowska‐Suchanek, I. (2021) · Cells · doi:10.3390/cells10010141 · Cited by 61
Xia, Y., Chen, T., Zhang, L., Zhang, X., Shi, W., Chen, G., Chen, W., Lan, J., Li, C., Sun, W., et al. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112834 · Cited by 59
Castro, F., Pereira, C. L., Macedo, M. H., Almeida, A., Silveira, M. J., Dias, S., Cardoso, A. P., Oliveira, M. J., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.06.001 · Cited by 62
April-Monn, S., Wiedmer, T., Skowronska, M., Maire, R., Lena, M. S., Trippel, M., Domenico, A. D., Muffatti, F., Andreasi, V., Capurso, G., et al. (2020) · Neuroendocrinology · doi:10.1159/000507669 · Cited by 59
Cavo, M., Cave, D. D., D’Amone, E., Gigli, G., Lonardo, E., & del Mercato, L. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-66908-8 · Cited by 57
Kim, T. Y., Kofron, C. M., King, M. E., Markes, A. R., Okundaye, A. O., Qu, Z., Mende, U., & Choi, B.-R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196714 · Cited by 57
Anticancer Activity of Bee Venom Components against Breast Cancer
Kwon, N.-Y., Sung, S.-H., Sung, H.-K., & Park, J.-K. (2022) · Toxins · doi:10.3390/toxins14070460 · Cited by 59
Self-filling microwell arrays (SFMAs) for tumor spheroid formation
Seyfoori, A., Samiei, E., Jalili, N., Godau, B., Rahmanian, M., Farahmand, L., Majidzadeh‐A, K., & Akbari, M. (2018) · Lab on a Chip · doi:10.1039/c8lc00708j · Cited by 58
The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration
Gunay, G., Kirit, H. A., Kamatar, A., Baghdasaryan, O., Hamsici, S., & Acar, H. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.09.002 · Cited by 56
Jamming in Embryogenesis and Cancer Progression
Blauth, E., Kubitschke, H., Gottheil, P., Grosser, S., & Käs, J. A. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.666709 · Cited by 57
Emerging trends in the methodology of environmental toxicology: 3D cell culture and its applications
Wang, H., Xu, T., & Yin, D. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159501 · Cited by 57
Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting
Anthon, S. G., & Valente, K. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314582 · Cited by 63
Automating a Magnetic 3D Spheroid Model Technology for High-Throughput Screening
Baillargeon, P., Shumate, J., Hou, S., Fernández-Vega, V., Marques, N., Souza, G. R., Seldin, J., Spicer, T., & Scampavia, L. D. (2019) · SLAS TECHNOLOGY · doi:10.1177/2472630319854337 · Cited by 56
Roy, V., Magne, B., Vaillancourt-Audet, M., Blais, M., Chabaud, S., Grammond, E., Piquet, L., Fradette, J., Laverdière, I., Moulin, V. J., et al. (2020) · BioMed Research International · doi:10.1155/2020/6051210 · Cited by 57
Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models
Filipiak-Duliban, A., Brodaczewska, K. K., Kajdasz, A., & Kiéda, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031166 · Cited by 59
Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research
Doctor, A., Seifert, V., Ullrich, M., Hauser, S., & Pietzsch, J. (2020) · Cancers · doi:10.3390/cancers12102765 · Cited by 53
Patient-derived xenografts as preclinical neuroblastoma models
Braekeveldt, N., & Bexell, D. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2687-8 · Cited by 54
Theiner, S., Malderen, S. J. M. V., Acker, T. V., Legin, A. A., Keppler, B. K., Vanhaecke, F., & Koellensperger, G. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02681 · Cited by 54
Tian, L., Gao, J., Garcia, I. M., Chen, H. J., Castaldi, A., & Chen, Y. (2020) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.399 · Cited by 54
Mapanao, A. K., Che, P. P., Sarogni, P., Sminia, P., Giovannetti, E., & Voliani, V. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1879047 · Cited by 57
Song, H., Cai, G.-H., Liang, J., Ao, D.-S., Wang, H., & Yang, Z.-H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00646-x · Cited by 52
Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin
Tieu, T., Wojnilowicz, M., Huda, P., Thurecht, K. J., Thissen, H. W., Voelcker, N. H., & Cifuentes‐Rius, A. (2020) · Biomaterials Science · doi:10.1039/d0bm01335h · Cited by 56
Erkan, E. P., Senfter, D., Madlener, S., Jungwirth, G., Ströbel, T., Saydam, N., & Saydam, O. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.78 · Cited by 53
Development of an in vitro cell-sheet cancer model for chemotherapeutic screening
Lee, J., Shin, D., & Roh, J. (2018) · Theranostics · doi:10.7150/thno.26439 · Cited by 52
Spatarelu, C.-P., Zhang, H., Nguyen, D., Han, X., Liu, R., Guo, Q., Notbohm, J., Fan, J., Liu, L., & Chen, Z. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01428 · Cited by 52
3D models of the bone marrow in health and disease: yesterday, today, and tomorrow
Raić, A., Naolou, T., Mohra, A., Chatterjee, C., & Lee‐Thedieck, C. (2018) · MRS Communications · doi:10.1557/mrc.2018.203 · Cited by 55
Three-dimensional tumor models: Promoting breakthroughs in nanotheranostics translational research
Mapanao, A. K., & Voliani, V. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2019.100552 · Cited by 53
Gupta, P., Pérez-Mancera, P. A., Kocher, H. M., Nisbet, A., Schettino, G., & Velliou, E. G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00290 · Cited by 56
Applicability of tumor spheroids forin vitrochemosensitivity assays
Hamilton, G., & Rath, B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1554055 · Cited by 50
Sunilkumar, D., Drishya, G., Chandrasekharan, A., Shaji, S. K., Bose, C., Jossart, J. N., Perry, J. J. P., Mishra, N., Kumar, G. B., & Nair, B. G. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113724 · Cited by 51
Järvinen, P. P., Bonabi, A., Jokinen, V. P., & Sikanen, T. M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000479 · Cited by 52
Magnetic 3D cell culture: State of the art and current advances
Caleffi, J. T., Aal, M. C. E., Gallindo, H. D. O. M., Caxali, G. H., Crulhas, B. P., Ribeiro, A. D. O., Souza, G. R., & Delella, F. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120028 · Cited by 51
Anticancer therapeutic efficacy of biogenic Am-ZnO nanoparticles on 2D and 3D tumor models
Chabattula, S. C., Gupta, P. K., Tripathi, S. K., Gahtori, R., Padhi, P., Mahapatra, S., Biswal, B. K., Singh, S. K., Dua, K., Ruokolainen, J., et al. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2021.100618 · Cited by 51
Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression
Díaz, E. C. G., Sinha, S., Avedian, R. S., & Yang, F. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.08.020 · Cited by 52
Ma, Z., Li, N., Zhang, B., Hui, Y., Zhang, Y., Lü, P., Pi, J., & Liu, Z. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00681-8 · Cited by 49
Butler, K. S., Brinker, C. J., & Leong, H. S. (2022) · ACS Nano · doi:10.1021/acsnano.2c03990 · Cited by 49
Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs
van den Brand, D., Massuger, L. F. A. G., Brock, R. E., & Verdurmen, W. P. R. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00699 · Cited by 50
Granja, A., Lima‐Sousa, R., Alves, C. G., de Melo‐Diogo, D., Pinheiro, M., Sousa, C. T., Correia, I. J., & Reis, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121044 · Cited by 47
Current methods in risk assessment of genotoxic chemicals
Cartus, A. T., & Schrenk, D. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.09.012 · Cited by 47
Arora, J., Sauer, S. J., Tarpley, M., Vermeulen, P. B., Rypens, C., Laere, S. V., Williams, K. P., Devi, G. R., & Dewhirst, M. W. (2017) · Oncotarget · doi:10.18632/oncotarget.15667 · Cited by 47
Self-citationRoy, S. M., Garg, V., Barman, S., Ghosh, C., Maity, A. R., & Ghosh, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.785937 · Cited by 49
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Gerigk, M., Bulstrode, H. J. C. J., Shi, H., Tönisen, F., Cerutti, C., Morrison, G. M., Rowitch, D. H., & Huang, Y. Y. S. (2021) · Lab on a Chip · doi:10.1039/d1lc00271f · Cited by 51
3D hanging spheroid plate for high-throughput CAR T cell cytotoxicity assay
Chen, Z., Han, S., Sanny, A., Chan, D. L.-K., van Noort, D., Lim, W., Tan, A. H., & Park, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01213-8 · Cited by 46
Luo, J., Cao, J., Ma, G., Wang, X., Sun, Y., Zhang, C., Shi, Z., Zeng, Y., Zhang, T., & Huang, P. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08951 · Cited by 47
Fabrication of Cell Spheroids for 3D Cell Culture and Biomedical Applications
Park, S. Y., Hong, H. J., & Lee, H. J. (2022) · BioChip Journal · doi:10.1007/s13206-022-00086-9 · Cited by 50
Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
Szaryńska, M., Olejniczak-Kęder, A., Kobiela, J., Łaski, D., Śledziński, Z., & Kmieć, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-30525-3 · Cited by 46
Reddy, T. S., Privér, S. H., Rao, V. V., Mirzadeh, N., & Bhargava, S. K. (2018) · Dalton Transactions · doi:10.1039/c8dt01724g · Cited by 46
Yoshimatsu, Y., Noguchi, R., Tsuchiya, R., Kito, F., Sei, A., Sugaya, J., Nakagawa, M., Yoshida, A., Iwata, S., Kawai, A., et al. (2020) · Human Cell · doi:10.1007/s13577-019-00312-x · Cited by 46
Stenberg, V. Y., Larsen, R. H., Ma, L., Peng, Q., Juzenas, P., Bruland, Ø. S., & Juzeniene, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094815 · Cited by 45
Bringing 3D tumor models to the clinic – predictive value for personalized medicine
Halfter, K., & Mayer, B. (2017) · Biotechnology Journal · doi:10.1002/biot.201600295 · Cited by 48
Engineered hydrogels for brain tumor culture and therapy
Thakor, J., Ahadian, S., Niakan, A. A., Banton, E. A., Nasrollahi, F., Hasani‐Sadrabadi, M. M., & Khademhosseini, A. (2020) · Bio-Design and Manufacturing · doi:10.1007/s42242-020-00084-6 · Cited by 43
Magnetic molding of tumor spheroids: emerging model for cancer screening
Perez, J. E., Nagle, I., & Wilhelm, C. (2020) · Biofabrication · doi:10.1088/1758-5090/abc670 · Cited by 52
SpheroidJ: An Open-Source Set of Tools for Spheroid Segmentation
Lacalle, D., Castro-Abril, H. A., Ranđelović, T., Domínguez, C., Heras, J., Mata, E. J., Mata, G., Méndez, Y., Pascual, V., & Ochoa, I. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105837 · Cited by 44
Zhang, Y., Wang, Z., Hu, Q., Luo, H., Lu, B., Gao, Y., Qiao, Z., Zhou, Y., Fang, Y., Gu, J., et al. (2022) · Small · doi:10.1002/smll.202200364 · Cited by 46
Advances in the application of 3D tumor models in precision oncology and drug screening
Guan, X., & Huang, S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1021966 · Cited by 45
Monfort, T., Azzollini, S., Brogard, J., Clémençon, M., Slembrouck-Brec, A., Forster, V., Picaud, S. A., Goureau, O., Reichman, S., Thouvenin, O., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05378-w · Cited by 48
In vitro characterization of spheres derived from colorectal cancer cell lines
Olejniczak-Kęder, A., Szaryńska, M., & Kmieć, Z. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4206 · Cited by 45
Totti, S., Allenby, M. C., Santos, S. B. D., Mantalaris, A., & Velliou, E. G. (2018) · RSC Advances · doi:10.1039/c8ra02633e · Cited by 44
Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications
Carmona-Ule, N., González-Conde, M., Abuín, C., Cueva, J. F., Palacios, P., López‐López, R., Costa, C., & Dávila-Ibáñez, A. B. (2021) · Cancers · doi:10.3390/cancers13112668 · Cited by 42
Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
Ponomarev, A., Gilazieva, Z., Solovyeva, V. V., Allegrucci, C., & Rizvanov, A. A. (2022) · Cancers · doi:10.3390/cancers14040970 · Cited by 45
SpheroidPicker for automated 3D cell culture manipulation using deep learning
Grexa, I., Diósdi, Á., Harmati, M., Kriston, A., Moshkov, N., Buzás, K., Pietiäinen, V., Koós, K., & Horváth, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-94217-1 · Cited by 43
Harnessing the power of artificial intelligence for human living organoid research
Wang, H., Li, X., You, X., & Zhao, G. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.027 · Cited by 43
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22475 · Cited by 43
Eglen, R. M., & Reisine, T. (2019) · SLAS TECHNOLOGY · doi:10.1177/2472630318803275 · Cited by 43
Remote Control in Formation of 3D Multicellular Assemblies Using Magnetic Forces
Jafari, J., Han, X., Palmer, J. A., Tran, P. A., & O’Connor, A. J. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00297 · Cited by 43
Hydrogels to engineer tumor microenvironments in vitro
Fernando, K., Kwang, L. G., Lim, J. T. C., & Fong, E. L. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01943g · Cited by 44
Extracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids
Lee, H. J., Mun, S., Pham, D. M., & Kim, P. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01801 · Cited by 44
Li, C., Li, J., Li, Y., Li, L., Luo, Y.-L., Li, J., Zhang, Y., Wang, Y., Liu, X., Zhou, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02620 · Cited by 42
3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response
Senrung, A., Lalwani, S., Janjua, D., Tripathi, T., Kaur, J., Ghuratia, N., Aggarwal, N., Chhokar, A., Yadav, J., Chaudhary, A., et al. (2023) · In vitro models · doi:10.1007/s44164-023-00059-8 · Cited by 48
Lee, J., Kim, K., Ryu, T. Y., Jung, C., Lee, M., Lim, J. H., Park, K., Kim, D., Son, M., Hamamoto, R., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13050 · Cited by 42
Sawant, S. S., Patil, S. M., Shukla, S. K., Kulkarni, N. S., Gupta, V., & Kunda, N. K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01088-0 · Cited by 42
A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer
Sonju, J. J., Dahal, A., Singh, S. S., Gu, X., Johnson, W. D., Muthumula, C. M. R., Meyer, S. A., & Jois, S. D. S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121364 · Cited by 42
Li, M., Yao, M., Wang, W., Wan, P., Chu, X., Zheng, Y., Yang, K., & Zhang, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.019 · Cited by 40
Ravi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 45
Metadata
- Authors
- Nath, S., & Devi, G. R.
- Affiliations
- Duke University (US)
- Corresponding author
- Devi, Gayathri R.
- ORCID
- Devi, Gayathri R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 163
- Pages
- 94-108
- ISSN
- 0163-7258 (ISSN-L)
- PMC
- PMC4961208
- OpenAlex
- W2332155194
- Cited by
- 919
- References
- 175
- Citations by year
- 2026: 67 · 2025: 95 · 2024: 100 · 2023: 92 · 2022: 110 · 2021: 125 · 2020: 137 · 2019: 81 · 2018: 63 · 2017: 38 · 2016: 11
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Pharmacology & Therapeutics (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (CA014236)
- Department of Defense (W81XWH-13-1-0047)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor spheroids, tumor cell culture, cell-matrix interactions, tumor heterogeneity, tumor-host interaction, high-throughput drug screening, anticancer drug discovery
- MeSH terms
- Antineoplastic Agents, Cell Communication, Cell Movement, Flow Cytometry, Humans, Microscopy, Electron, Scanning, Neoplasm Invasiveness, Neoplasms, Tumor Cells, Cultured, Microscopy, Confocal, Spheroids, Cellular, Cell Culture Techniques, Hydrogels, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
